FCF YoY
+22.13%
OCF YoY
+11.33%
Capex YoY
-42.72%
FCF Conversion Δ
+8.1 pp
Free cash flow bridge for Bio-Techne (TECH) — TTM through Q1 2026 vs TTM through Q1 2025
Δ Free cash flow: $48.84M
FCF bridge breakdown for Bio-Techne (TECH) — TTM through Q1 2026 vs TTM through Q1 2025
| Driver | Contribution | % of Δ |
|---|---|---|
| Prior Free Cash Flow | $220.75M | — |
| Operating Cash Flow | $30.01M | +61.4% |
| Capital Expenditure | $18.84M | +38.6% |
| Free Cash Flow | $269.60M | — |
- Prior Free Cash Flow$220.75M
- Operating Cash Flow$30.01M
- Capital Expenditure$18.84M
- Free Cash Flow$269.60M
Identity check: drivers reconcile to ΔNI within $0.00 ✓
Want to see how cash flow is built up?Cash Flow Waterfall
Frequently asked questions
Data & methodology
Bio-Techne (TECH) Key Financials
Charts, filings, and peer comparison for every metric
Income Statement
Balance Sheet
Cash Flow
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation
Overview
Income Statement